The Global State of Specialty Pharmacy: Insights Across Borders

Specialty medications—used to treat complex conditions such as oncology, autoimmune disorders, multiple sclerosis, and rare diseases—require specialized care and unique pharmacy management models. These medications are often costly, require intensive clinical oversight, and present operational challenges that differ across regions. This presentation and panel discussion will bring together specialty pharmacy experts from the United States (US), the United Arab Emirates (UAE), Canada, and other countries to provide a global perspective on specialty pharmacy models. Panellists will explore clinical, operational, and quality strategies, offering valuable insights into how specialty pharmacy care is delivered in their respective regions.

Moderator:

- Rafa Al Khalifa, Associate Director of Specialty Pharmacy Services/Social and Administrative Pharmacy Liaison, Al Thiqa Pharmacy/FIP ECPG, Sudan/UAE

Facilitator:

- Lynnae Mahaney, VP of Business Development, Specia, USA

Panellists:

- Idan Reichhardt, Pharmacist, Pharmacie Michael Assaraf (affiliated with Sanavie) Pharmacy, Canada

- Ann-Laurence Brière, Pharmacist, Pharmacie Michael Assaraf (affiliated with Sanavie) Pharmacy, Canada

- Jill Paslier, CEO/Founder, Specia LLC & Paslier Consulting LLC, USA

- Zakieh Abuelkhair, Director of Pharmacy Operations, Al Thiqa Pharmacy Group, UAE